Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $6.03, $1.08 better than the analyst estimate of $4.95. Revenue for the quarter came in at $50.09 billion versus the consensus estimate of $49.34 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.